Kaye Foster

Board Member (nasdaq: Prime) at Prime Medicine

Kaye Foster is a seasoned executive with extensive experience in advisory and leadership roles across various industries. Currently serving as a Senior Advisor and Executive Coach at Boston Consulting Group since 2014, Kaye collaborates with C-suite executives to enhance organizational performance, including guiding CEO transitions post-M&A for a $2B public company. Kaye holds multiple board positions, including Trustee roles at Stanford Health Care and Spelman College, and serves as a Board Member for various organizations such as Agios Pharmaceuticals and Prime Medicine, Inc. Previously, Kaye worked as Senior Vice President of Global Human Resources at Onyx Pharmaceuticals, playing a key role in transforming the company into a global entity and implementing a comprehensive talent management plan. Kaye's career also includes a significant tenure at Johnson & Johnson as Vice President of Human Resources. Educational qualifications include an MBA from Columbia Business School and a BBA from Baruch College.

Location

Nyack, United States

Links


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Prime Medicine

4 followers

Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of DNA. A single Prime Editor can correct the individual mutations found across patients, meaning Prime Editing can potentially address more than 90 percent of known disease-causing genetic mutations. We envision a world where this technology can cure, halt, and ultimately prevent genetic diseases, providing lifelong benefit to patients. Prime Medicine offers the opportunity to shape the future of gene editing and transform how medicines are used to treat disease. Realizing the promise of Prime Editing requires a talented team with diversity of viewpoints and expertise. We’re building a group of dedicated, scientifically curious individuals who are passionate about helping patients live longer, healthier lives.


Industries

Employees

51-200

Links